Maeda Akiko, Nabeya Daijiro, Nagano Hiroaki, Yagi Nobuhito, Miyagi Tadayoshi, Kishaba Tomoo
Department of Respiratory Internal Medicine Okinawa Chubu Hospital Okinawa Japan.
Department of Cardiovascular Medicine Okinawa Chubu Hospital Okinawa Japan.
Respirol Case Rep. 2020 Dec 15;9(1):e00700. doi: 10.1002/rcr2.700. eCollection 2021 Jan.
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), which causes coronavirus disease 2019 (COVID-19), has resulted in significant morbidity and mortality worldwide. Approximately 5% of COVID-19 patients who suffer from pneumonia develop critical respiratory failure. Here, we report the case of a healthy 52-year-old man who had respiratory failure owing to SARS-CoV-2 infection and was treated using femoro-femoral veno-venous extracorporeal membrane oxygenation (VV-ECMO) and prone position ventilation (PPV). After this treatment, his blood oxygen levels, chest high-resolution computed tomography findings, and clinical parameters significantly improved. He was decannulated from VV-ECMO on day 6 and finally extubated on day 11. To our knowledge, this is the first reported case of SARS-CoV-2-associated acute respiratory distress syndrome that was successfully treated with a combination of femoro-femoral VV-ECMO and PPV.
严重急性呼吸综合征冠状病毒2（SARS-CoV-2）引发了2019冠状病毒病（COVID-19），在全球范围内导致了大量发病和死亡。约5%的COVID-19肺炎患者会发展为严重呼吸衰竭。在此，我们报告一例52岁健康男性病例，该患者因感染SARS-CoV-2而出现呼吸衰竭，接受了股-股静脉-静脉体外膜肺氧合（VV-ECMO）和俯卧位通气（PPV）治疗。经过此治疗后，他的血氧水平、胸部高分辨率计算机断层扫描结果及临床参数均显著改善。他在第6天撤掉了VV-ECMO插管，并最终在第11天拔管。据我们所知，这是首例报告的通过股-股VV-ECMO和PPV联合成功治疗的SARS-CoV-2相关急性呼吸窘迫综合征病例。
